MORGAN STANLEY - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 57 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$612,265
+18.6%
53,473
+6.5%
0.00%
Q2 2023$516,097
+139.5%
50,204
+79.9%
0.00%
Q1 2023$215,496
+67.0%
27,914
+59.0%
0.00%
Q4 2022$129,073
+53.7%
17,561
+51.9%
0.00%
Q3 2022$84,000
-25.0%
11,562
-12.4%
0.00%
Q2 2022$112,000
+34.9%
13,199
+42.3%
0.00%
Q1 2022$83,000
-34.6%
9,277
+1.4%
0.00%
Q4 2021$127,000
+353.6%
9,145
+234.5%
0.00%
Q3 2021$28,000
-6.7%
2,734
-17.8%
0.00%
Q2 2021$30,000
-47.4%
3,326
-37.8%
0.00%
Q1 2021$57,000
-98.8%
5,350
-98.6%
0.00%
-100.0%
Q4 2020$4,759,000
+22561.9%
377,723
+15527.8%
0.00%
Q3 2020$21,000
-47.5%
2,417
-40.7%
0.00%
Q2 2020$40,0004,075
+58114.3%
0.00%
Q1 2020$07
-66.7%
0.00%
Q4 2019$021
-16.0%
0.00%
Q3 2019$0
-100.0%
25
-99.6%
0.00%
Q2 2019$29,000
-35.6%
6,879
+5.2%
0.00%
Q1 2019$45,000
+55.2%
6,538
-14.9%
0.00%
Q4 2018$29,000
+314.3%
7,684
+641.0%
0.00%
Q3 2018$7,000
-12.5%
1,0370.0%0.00%
Q2 2018$8,000
-27.3%
1,037
-28.1%
0.00%
Q1 2018$11,000
-8.3%
1,443
+39.2%
0.00%
Q4 2017$12,000
-58.6%
1,037
-59.1%
0.00%
Q3 2017$29,0002,5370.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$23,143,0002.13%
Omega Fund Management, LLC 1,284,900$11,564,0001.31%
Avidity Partners Management LP 1,495,000$13,455,0000.36%
Samsara BioCapital, LLC 275,169$2,477,0000.31%
Orbimed Advisors 3,070,955$27,639,0000.28%
Ikarian Capital, LLC 300,454$2,704,0000.22%
TIGER MANAGEMENT L.L.C. 137,728$1,240,0000.22%
DAFNA Capital Management LLC 113,302$1,020,0000.21%
EcoR1 Capital, LLC 522,635$4,704,0000.18%
Artal Group S.A. 593,030$5,337,0000.11%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders